부산대학교 도서관

Foy B; University of Colorado, Anschutz Medical Campus, School of Medicine, 13001 E 17th Pl, Aurora, CO, USA. Electronic address: Bridget.foy@cuanschutz.edu.; Ludwigson A; University of Colorado, Anschutz Medical Campus, School of Medicine, 13001 E 17th Pl, Aurora, CO, USA.; Mott NM; University of Colorado, Anschutz Medical Campus, Department of Surgery, 12631 E 17th Ave, Aurora, CO, USA.; Adams M; University of Colorado, School of Medicine, Adult and Child Center for Outcomes Research and Delivery Science (ACCORDS), 1890, N Revere Ct, Aurora, CO, USA.; Higgins MG; University of Colorado, Anschutz Medical Campus, Department of Surgery, 12631 E 17th Ave, Aurora, CO, USA.; Vemuru S; University of Colorado, Anschutz Medical Campus, Department of Surgery, 12631 E 17th Ave, Aurora, CO, USA.; Wolverton D; University of Colorado, Anschutz Medical Campus, Department of Radiology, 12401 E 17th Ave, Aurora, CO, USA.; Yi J; University of Colorado, Anschutz Medical Campus, Department of Surgery, 12631 E 17th Ave, Aurora, CO, USA.; Sams S; University of Colorado, Anschutz Medical Campus, Department of Pathology, 12631 E 17th Ave, Aurora, CO, USA.; Lin CT; University of Colorado, Anschutz Medical Campus, Department of Medicine, 12631 E 17th Ave, Aurora, CO, USA.; Miles R; University of Colorado, Anschutz Medical Campus, Department of Radiology, 12401 E 17th Ave, Aurora, CO, USA.; Taft N; Denver Health Medical Center, Department of Surgery, 777 Bannock St, Denver, CO, USA.; Baurle E; University of Colorado, Anschutz Medical Campus, School of Medicine, 13001 E 17th Pl, Aurora, CO, USA.; Cumbler E; University of Colorado, Anschutz Medical Campus, Department of Medicine, 12631 E 17th Ave, Aurora, CO, USA.; Tevis S; University of Colorado, Anschutz Medical Campus, Department of Surgery, 12631 E 17th Ave, Aurora, CO, USA.

Publisher: Excerpta Medica Country of Publication: United States NLM ID: 0370473 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-1883 (Electronic) Linking ISSN: 00029610 NLM ISO Abbreviation: Am J Surg Subsets: MEDLINE

Lucas Kuhlen; Steven Johnson; Andreas Zeitler; Sandra Bäurle; Justin C. Deme; Joseph J. E. Caesar; Rebecca Debo; Joseph Fisher; Samuel Wagner; Susan M. Lea

Nature Communications, Vol 11, Iss 1, Pp 1-10 (2020)

Kuhlen, Lucas; Johnson, Steven; Zeitler, Andreas; Bäurle, Sandra; Deme, Justin C.; Caesar, Joseph J.  E.; Debo, Rebecca; Fisher, Joseph; Wagner, Samuel; Lea, Susan M.

Nature Communications. 11(1)

Crawford T; Institute for Biochemistry and Biology, University of Potsdam, Potsdam, Germany.; Siebler L; Institute for Biochemistry and Biology, University of Potsdam, Potsdam, Germany.; Sulkowska A; Institute for Biochemistry and Biology, University of Potsdam, Potsdam, Germany.; Nowack B; Institute for Biochemistry and Biology, University of Potsdam, Potsdam, Germany.; Jiang L; Institute for Biochemistry and Biology, University of Potsdam, Potsdam, Germany.; Pan Y; Institute for Biochemistry and Biology, University of Potsdam, Potsdam, Germany.; Lämke J; Institute for Biochemistry and Biology, University of Potsdam, Potsdam, Germany.; Kappel C; Institute for Biochemistry and Biology, University of Potsdam, Potsdam, Germany.; Bäurle I; Institute for Biochemistry and Biology, University of Potsdam, Potsdam, Germany. isabel.baeurle@uni-potsdam.de.

Publisher: Wiley Blackwell Country of Publication: England NLM ID: 8208664 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1460-2075 (Electronic) Linking ISSN: 02614189 NLM ISO Abbreviation: EMBO J Subsets: MEDLINE

Drozda, Tomasz G; Lampenfield, Jacob J; Deshmukh, Rohan G; Baurle, Robert A; Drummond, J. Philip

Langer G; Bayer AG, Research & Development, Pharmaceuticals, Berlin, Germany (G.L., U.B., J.M., B.l.R., S.B.); Bayer AG, Research & Development, Pharmaceuticals, Wuppertal, Germany (C.O., A.L.-B.); Innovation Campus Berlin, a Nuvisan Company, Berlin, Germany (H.I., K.N.-R.); Evotec SE, Hamburg, Germany (A.S., M.S.); and Evotec (UK) Ltd, Abingdon, Oxfordshire, United Kingdom (J.S., C.L., A.J.D.) stefan.baeurle@bayer.com gernot.langer@bayer.com.; Scott J; Bayer AG, Research & Development, Pharmaceuticals, Berlin, Germany (G.L., U.B., J.M., B.l.R., S.B.); Bayer AG, Research & Development, Pharmaceuticals, Wuppertal, Germany (C.O., A.L.-B.); Innovation Campus Berlin, a Nuvisan Company, Berlin, Germany (H.I., K.N.-R.); Evotec SE, Hamburg, Germany (A.S., M.S.); and Evotec (UK) Ltd, Abingdon, Oxfordshire, United Kingdom (J.S., C.L., A.J.D.).; Lind C; Bayer AG, Research & Development, Pharmaceuticals, Berlin, Germany (G.L., U.B., J.M., B.l.R., S.B.); Bayer AG, Research & Development, Pharmaceuticals, Wuppertal, Germany (C.O., A.L.-B.); Innovation Campus Berlin, a Nuvisan Company, Berlin, Germany (H.I., K.N.-R.); Evotec SE, Hamburg, Germany (A.S., M.S.); and Evotec (UK) Ltd, Abingdon, Oxfordshire, United Kingdom (J.S., C.L., A.J.D.).; Otto C; Bayer AG, Research & Development, Pharmaceuticals, Berlin, Germany (G.L., U.B., J.M., B.l.R., S.B.); Bayer AG, Research & Development, Pharmaceuticals, Wuppertal, Germany (C.O., A.L.-B.); Innovation Campus Berlin, a Nuvisan Company, Berlin, Germany (H.I., K.N.-R.); Evotec SE, Hamburg, Germany (A.S., M.S.); and Evotec (UK) Ltd, Abingdon, Oxfordshire, United Kingdom (J.S., C.L., A.J.D.).; Bothe U; Bayer AG, Research & Development, Pharmaceuticals, Berlin, Germany (G.L., U.B., J.M., B.l.R., S.B.); Bayer AG, Research & Development, Pharmaceuticals, Wuppertal, Germany (C.O., A.L.-B.); Innovation Campus Berlin, a Nuvisan Company, Berlin, Germany (H.I., K.N.-R.); Evotec SE, Hamburg, Germany (A.S., M.S.); and Evotec (UK) Ltd, Abingdon, Oxfordshire, United Kingdom (J.S., C.L., A.J.D.).; Laux-Biehlmann A; Bayer AG, Research & Development, Pharmaceuticals, Berlin, Germany (G.L., U.B., J.M., B.l.R., S.B.); Bayer AG, Research & Development, Pharmaceuticals, Wuppertal, Germany (C.O., A.L.-B.); Innovation Campus Berlin, a Nuvisan Company, Berlin, Germany (H.I., K.N.-R.); Evotec SE, Hamburg, Germany (A.S., M.S.); and Evotec (UK) Ltd, Abingdon, Oxfordshire, United Kingdom (J.S., C.L., A.J.D.).; Müller J; Bayer AG, Research & Development, Pharmaceuticals, Berlin, Germany (G.L., U.B., J.M., B.l.R., S.B.); Bayer AG, Research & Development, Pharmaceuticals, Wuppertal, Germany (C.O., A.L.-B.); Innovation Campus Berlin, a Nuvisan Company, Berlin, Germany (H.I., K.N.-R.); Evotec SE, Hamburg, Germany (A.S., M.S.); and Evotec (UK) Ltd, Abingdon, Oxfordshire, United Kingdom (J.S., C.L., A.J.D.).; le Roy B; Bayer AG, Research & Development, Pharmaceuticals, Berlin, Germany (G.L., U.B., J.M., B.l.R., S.B.); Bayer AG, Research & Development, Pharmaceuticals, Wuppertal, Germany (C.O., A.L.-B.); Innovation Campus Berlin, a Nuvisan Company, Berlin, Germany (H.I., K.N.-R.); Evotec SE, Hamburg, Germany (A.S., M.S.); and Evotec (UK) Ltd, Abingdon, Oxfordshire, United Kingdom (J.S., C.L., A.J.D.).; Irlbacher H; Bayer AG, Research & Development, Pharmaceuticals, Berlin, Germany (G.L., U.B., J.M., B.l.R., S.B.); Bayer AG, Research & Development, Pharmaceuticals, Wuppertal, Germany (C.O., A.L.-B.); Innovation Campus Berlin, a Nuvisan Company, Berlin, Germany (H.I., K.N.-R.); Evotec SE, Hamburg, Germany (A.S., M.S.); and Evotec (UK) Ltd, Abingdon, Oxfordshire, United Kingdom (J.S., C.L., A.J.D.).; Nowak-Reppel K; Bayer AG, Research & Development, Pharmaceuticals, Berlin, Germany (G.L., U.B., J.M., B.l.R., S.B.); Bayer AG, Research & Development, Pharmaceuticals, Wuppertal, Germany (C.O., A.L.-B.); Innovation Campus Berlin, a Nuvisan Company, Berlin, Germany (H.I., K.N.-R.); Evotec SE, Hamburg, Germany (A.S., M.S.); and Evotec (UK) Ltd, Abingdon, Oxfordshire, United Kingdom (J.S., C.L., A.J.D.).; Schlüter A; Bayer AG, Research & Development, Pharmaceuticals, Berlin, Germany (G.L., U.B., J.M., B.l.R., S.B.); Bayer AG, Research & Development, Pharmaceuticals, Wuppertal, Germany (C.O., A.L.-B.); Innovation Campus Berlin, a Nuvisan Company, Berlin, Germany (H.I., K.N.-R.); Evotec SE, Hamburg, Germany (A.S., M.S.); and Evotec (UK) Ltd, Abingdon, Oxfordshire, United Kingdom (J.S., C.L., A.J.D.).; Davenport AJ; Bayer AG, Research & Development, Pharmaceuticals, Berlin, Germany (G.L., U.B., J.M., B.l.R., S.B.); Bayer AG, Research & Development, Pharmaceuticals, Wuppertal, Germany (C.O., A.L.-B.); Innovation Campus Berlin, a Nuvisan Company, Berlin, Germany (H.I., K.N.-R.); Evotec SE, Hamburg, Germany (A.S., M.S.); and Evotec (UK) Ltd, Abingdon, Oxfordshire, United Kingdom (J.S., C.L., A.J.D.).; Slack M; Bayer AG, Research & Development, Pharmaceuticals, Berlin, Germany (G.L., U.B., J.M., B.l.R., S.B.); Bayer AG, Research & Development, Pharmaceuticals, Wuppertal, Germany (C.O., A.L.-B.); Innovation Campus Berlin, a Nuvisan Company, Berlin, Germany (H.I., K.N.-R.); Evotec SE, Hamburg, Germany (A.S., M.S.); and Evotec (UK) Ltd, Abingdon, Oxfordshire, United Kingdom (J.S., C.L., A.J.D.).; Bäurle S; Bayer AG, Research & Development, Pharmaceuticals, Berlin, Germany (G.L., U.B., J.M., B.l.R., S.B.); Bayer AG, Research & Development, Pharmaceuticals, Wuppertal, Germany (C.O., A.L.-B.); Innovation Campus Berlin, a Nuvisan Company, Berlin, Germany (H.I., K.N.-R.); Evotec SE, Hamburg, Germany (A.S., M.S.); and Evotec (UK) Ltd, Abingdon, Oxfordshire, United Kingdom (J.S., C.L., A.J.D.) stefan.baeurle@bayer.com gernot.langer@bayer.com.

Publisher: American Society for Pharmacology and Experimental Therapeutics Country of Publication: United States NLM ID: 0035623 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-0111 (Electronic) Linking ISSN: 0026895X NLM ISO Abbreviation: Mol Pharmacol Subsets: MEDLINE

Drozda, Tomasz G; Shenoy, Rajiv R; Passe, Bradley J; Baurle, Robert A; Drummond, J. Philip

Shenoy, Rajiv R; Drozda, Tomasz G; Norris, Andrew T; Baurle, Robert A; Drummond, J. Philip

White, Jeffery A; Baurle, Robert A; Passe, Bradley J; Spiegel, Seth C; Nishikawa, Hiroaki

Lackey, R.J.; Baurle, H.F.; Barile, J.

MILCOM 88, 21st Century Military Communications - What's Possible?'. Conference record. Military Communications Conference Military Communications Conference, 1988. MILCOM 88, Conference record. 21st Century Military Communications - What's Possible? 1988 IEEE. :205-209 vol.1 1988